Key regions: Brazil, India, Australia, United States, United Kingdom
The Antiviral Drugs market in Mozambique has seen significant growth in recent years.
Customer preferences: Antiviral drugs are used to treat viral infections, and their demand has increased due to the COVID-19 pandemic. Mozambique has a high burden of infectious diseases, including HIV, malaria, and tuberculosis, which has led to a high demand for antiviral drugs in the country.
Trends in the market: The market for antiviral drugs in Mozambique has been growing steadily due to the increasing prevalence of infectious diseases in the country. The COVID-19 pandemic has also contributed to the growth of the market, as the demand for antiviral drugs has increased significantly. The government has taken steps to ensure that antiviral drugs are available to those who need them, and this has contributed to the growth of the market.
Local special circumstances: Mozambique is a low-income country with limited resources, and this has had an impact on the availability of antiviral drugs in the country. The government has taken steps to address this issue, including partnering with international organizations to provide antiviral drugs to those who need them. The country also has a high burden of infectious diseases, which has led to a high demand for antiviral drugs.
Underlying macroeconomic factors: Mozambique is one of the poorest countries in the world, with a GDP per capita of less than $500. The country has a high burden of infectious diseases, which has led to a high demand for antiviral drugs. The government has taken steps to address this issue, including partnering with international organizations to provide antiviral drugs to those who need them. The COVID-19 pandemic has also contributed to the growth of the market, as the demand for antiviral drugs has increased significantly. Despite these challenges, the market for antiviral drugs in Mozambique is expected to continue growing in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
